Overview

Causes of Visual Loss in Retinal Disease

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This is a study of visual outcomes in retinal disease that seeks to identify the causes of visual loss. This data will be used to predict which patients are at risk of losing vision and how they can be better treated.
Details
Lead Sponsor:
Royal Surrey County Hospital
Royal Surrey County Hospital NHS Foundation Trust
Treatments:
Adalimumab
Azathioprine
Cyclosporine
Cyclosporins
Etanercept
Immunosuppressive Agents
Infliximab
Methotrexate
Mycophenolate mofetil
Mycophenolic Acid
Prednisolone